These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects. Conte A; Roca P; Genestar C; Grases F Nephron; 1989; 52(2):162-5. PubMed ID: 2500615 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol. Tiselius HG Br J Urol; 1980 Jun; 52(3):189-92. PubMed ID: 7426978 [TBL] [Abstract][Full Text] [Related]
26. Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets. Urivetzky M; Braverman S; Motola JA; Smith AD J Urol; 1990 Jul; 144(1):97-8. PubMed ID: 2359187 [TBL] [Abstract][Full Text] [Related]
27. Placebo versus allopurinol for recurrent urinary calculi. Smith MJ Proc Eur Dial Transplant Assoc; 1983; 20():422-6. PubMed ID: 6361753 [No Abstract] [Full Text] [Related]
28. Proceedings: Urinary excretion of oxalate, calcium, magnesium, and uric acid in inflammatory bowel disease and relationship to urolithiasis. Farmer RG; Mir-Madjlessi SH; Kiser WS Gut; 1973 Oct; 14(10):828. PubMed ID: 4758698 [No Abstract] [Full Text] [Related]
29. [Urinary calculus protective side effects of anti-rheumatic therapy]. Schlichter A; Brundig P Z Urol Nephrol; 1990 Apr; 83(4):175-81. PubMed ID: 2378178 [TBL] [Abstract][Full Text] [Related]
30. Prophylaxis of idiopathic and gouty uric acid lithiasis by allopurinol. de Vries A; Frank M Urol Int; 1967; 22(6):506-16. PubMed ID: 5590840 [No Abstract] [Full Text] [Related]
31. [The value attached to clinical laboratory findings in urolithiasis (author's transl)]. Zechner O; Höltl G; Zekoff K; Zekert F Wien Klin Wochenschr; 1974 Nov; 86(21):654-7. PubMed ID: 4428778 [No Abstract] [Full Text] [Related]
32. [Metabolic factors associated with urolithiasis. Part II (author's transl)]. Kuska J Przegl Lek; 1974; 31(12):982-6. PubMed ID: 4614334 [No Abstract] [Full Text] [Related]
35. Allopurinol control of hyperuricosuria: a new concept in the prevention of uric acid stones. Anderson EE; Rundles RW; Silberman HR; Metz EN J Urol; 1967 Feb; 97(2):344-7. PubMed ID: 6018433 [No Abstract] [Full Text] [Related]
36. [Hyperuricosuria and urolithiasis]. Koide T Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104 [TBL] [Abstract][Full Text] [Related]
37. [Medicinal teas in the prophylaxis of urinary calculus. Effect of solubitrat on the excretion of lithogenic and inhibitory substances (author's transl)]. Hesse A; Strenge A; Bach D; Vahlensieck W MMW Munch Med Wochenschr; 1981 Mar; 123(13):521-4. PubMed ID: 6785581 [TBL] [Abstract][Full Text] [Related]
38. Acute acid load in recurrent oxalate stone formers. Knispel HH; Fitzner R; Kaiser M; Butz M Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639 [TBL] [Abstract][Full Text] [Related]
39. Should recurrent calcium oxalate stone formers become vegetarians? Robertson WG; Peacock M; Heyburn PJ; Hanes FA; Rutherford A; Clementson E; Swaminathan R; Clark PB Br J Urol; 1979 Dec; 51(6):427-31. PubMed ID: 534817 [TBL] [Abstract][Full Text] [Related]
40. [Studies on oxalate in urolithiasis. II. Urinary oxalate in oxalate stone-formers (author's transl)]. Ogawa Y Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1546-52. PubMed ID: 7345192 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]